183
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Decreased paraoxonase 2 enzymatic activity in monocyte/macrophages cells. A comparative in vivo and in vitro study for diabetes

, , , , , & show all
Pages 604-615 | Received 07 Jul 2016, Accepted 18 Jun 2017, Published online: 13 Jul 2017

References

  • Allbrink M, May E. Serum tryglycerides in health and disease. Diabetes 1958;7:154.
  • Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801–809.
  • Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000;102:2180–2184.
  • Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213–219.
  • Havel R. McCollum Award Lecture, 1993: triglyceride-rich lipoproteins and atherosclerosis-new perspectives. Am J Clin Nutr 1994;59:795–799.
  • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813–820.
  • King George L, Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 1996;25:255–270.
  • Hiramatsu K, Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes 1988;37:832–837.
  • Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000;85:2970–2973.
  • Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002;75:767–772.
  • Klein RL, Wohltmann HJ, Lopes-Virella MF. Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages. Diabetes 1992;41:1301–1307.
  • Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998;394:284–287.
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–553.
  • Friedewald WT, Levy RT, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419.
  • Defacque H, Dornand J, Commes T, Cabane S, Sevilla C. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines. J Pharmacol Exp Ther 1994;271:193–199.
  • Allen RC, Loose LD. Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun 1976;69:245–252.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
  • Draganov DI, Stetson PL, Watson CE, Billecke SS, La Du BN. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 2000;275:33435–33442.
  • Redgrave TG, Carlson LA. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J. Lipid Res 1979;20:217–229.
  • Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83–97.
  • McEneny J, McMaster C, Trimble ER, Young IS. Rapid isolation of VLDL subfractions: assessment of composition and susceptibility to copper-mediated oxidation. J Lipid Res 2002;43:824–831.
  • Manuel-y-Keenoy B, de Vos C, Van Campenhout A, Vinckx M, Abrams P, Van Campenhout C. Divergent in vitro and in vivo lipid peroxidation in the postprandial phase of patients with type I diabetes mellitus. Eur J Clin Nutr 2008;62:401–410.
  • Peterson GL. Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall. Anal Biochem 1979;100:201–220.
  • Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 1995;15:1812–1818.
  • Ferretti G, Bacchetti T, Busni D, Rabini RA, Curatola G. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. J Clin Endocrinol Metab 2004;89:2957–2962.
  • Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 2002;32:259–264.
  • Devarajan A, Bourquard N, Hama S, Navab M, Grijalva VR. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid Redox Signal 2011;14:341–351.
  • Holven KB, Retterstøl K, Ueland T, Ulven SM, Nenseter MS, Sandvik M, et al. Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype. PLoS One 2013;8:e78241.
  • Aviram M, Kaplan M, Rosenblat M, Fuhrman B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol 2005;170:263–300.
  • Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004;37:1304–1316.
  • Hor-Yue T, Ning W, Sha L, Ming H, Xuanbin W, Yibin F. The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases. Oxid Med Cell Longev 2016;16:Article ID 2795090.
  • Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058–1070.
  • Ceolotto G, Sartori M, Felice M, Clari G, Bordin L, Semplicini A. Effect of protein kinase C and insulin on Na+/H + exchange in red blood cells of essential hypertensives. J Hum Hypertens 1999;13:321–327.
  • Bierhaus A, Schiekofer S, Schwaninger M, Andrassy M, Humpert PM, Chen J, et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001;50:2792–2808.
  • Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M, Hedrick CC. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2014;47:1727–1734.
  • Jiménez-Osorio AS, Picazo A, González-Reyes S, Barrera-Oviedo D, Rodríguez-Arellano ME, Pedraza-Chaverri J. Nrf2 and redox status in prediabetic and diabetic patients. Int J Mol Sci 2014;15:20290–20305.
  • Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension clinical implications and therapeutic possibilities. Diabetes Care 2008;31(Suppl. 2):S170–S180.
  • Yuan H, Lu Y, Huang X, He Q, Man Y, Zhou Y, et al. Suppression of NADPH oxidase 2 substantially restores glucose-induced dysfunction of pancreatic NIT-1 cells. FEBS J 2010;277:5061–5071.
  • Savu O, Ionescu-Tirgoviste C, Atanasiu V, Gaman L, Papacocea R. Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Int Med Res 2012;40:709–716.
  • Bacanu E, Lixandru D, Stoian I, Virgolici B, Mohora M. Correlations between obesity antropometric markers, adipocytokines and monocytes oxidative stress status in type 2 diabetic patients. Farmacia 2012;60:21–32.
  • Witte I, Foersterman U, Devarajan A, Reddy T, Horke S. Protectors or traitors: the roles of PON2 and PON3 in atherosclerosis and cancer. J Lipids 2012;2012:342806. doi:10.1155/2012/342806
  • Witte I, Altenhofer S, Wilgenbus P. Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells. Cell Death Dis 2011;2:e112. doi:10.1038/cddis.2010.91
  • Kota SK, Mehler LK, Kota S, Jammula S, Krishna SVS, Modi KD. Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia. Indian J Endocr Metab 2013;17:402–412.
  • Chateau MT, Rabesandratana H, Caravano R. Differentiated U937 cells and human monocytes exhibit a differential production of extracellular oxygen species: O2.- excretion versus H2O2 diffusion. FEMS Immunol Med Microbiol 1996;13:19–28.
  • Barbieri SS, Eligini S, Brambilla M, Tremoli E, Colli S. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc Res 2003;60:187–197.
  • Anrather J, Racchumi G, Iadecola C. NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 2006; 281:5657–5667.
  • Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:23–28.
  • Rosenblat M, Volkova N, RoquetaRivera M. Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6desaturase knockout (6DS KO) mice: beneficial effects of arachidonic acid. Atherosclerosis 2010;210: 414–421.
  • Shiner M, Fuhrman B, Aviram M. Macrophage paraoxonase 2 (PON2) expression is upregulated by pomegranate juice phenolic antioxidants via PPAR gamma and AP1 pathway activation. Atherosclerosis 2007;195:313–321.
  • Rosenblat M, Aviram M. Pomegranate juice protects macrophages from triglyceride accumulation: inhibitory effect on DGAT1 activity and on triglyceride biosynthesis. Ann Nutr Metab 2011;58:1–9.
  • Gavella M, Lipovac V, Car Z, Vucic M. Baseline diene conjugation in LDL lipids from newly diagnosed type 2 diabetic patients. Diab Metab 2002;28:391–396.
  • Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Methods Mol Biol 2010;610:403–417.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.